in white patients with open-angle <strong>glaucoma</strong>. Ophthalmology 2001;108:254-258. 128) Stegmann R, Pienaar A, Miller D. Viscocanalostomy <strong>for</strong> open-angle <strong>glaucoma</strong> in black African patients. J Cataract Refract Surg 1999;25:316-322. 129) Mermoud A. Sinustomy <strong>and</strong> deep sclerectomy. Eye 2000;14:531-535. 130) Van Buskirk EM. The sartorial spector of viscocanalostomy. J Glaucoma 2001;10:1-3. 131) Khaw PT, Migdal CS. Current techniques in wound healing modulation in <strong>glaucoma</strong> surgery. Current Opin. Ophthalmology 1996;7:24-33. 132) Lavin MJ, Wormald RPL, Migdal C, Hitchings RA. The influence of prior therapy on the success of trabeculectomy. Arch. Ophthalmol 1990;108:1543-1548. 133) Siriwardena D, Khaw PT, King AJ, Donaldson ML, Overton BM, Migdal G, Cordeiro MF. Human Antitras<strong>for</strong>ming Growth Factor β2 Monoclonal Antibody. A new modulator of wound healing in Trabeculectomy. A r<strong>and</strong>omized placebo controlled clinical study. Ophthalmology 2002;109:427-431. 134) Mills RP, Reynolds A, Edmond MJ, Barlow WE, Leen MM. Long-term survival of Molteno <strong>glaucoma</strong> drainage devices. Ophthalmology 1996;103:299-305. 135) Molteno ACB, Sayawat N, Herbison P. Otago <strong>glaucoma</strong> surgery outcome study. Long-term results of uveitis with secondary <strong>glaucoma</strong> drained by Molteno implants. Ophthalmology 2001;108:605-613. 136) Airaksinen PJ, Aisala P, Tuulonen A. Molteno implant surgery in uncontrolled <strong>glaucoma</strong>. Acta Ophthalmol 1990;68:690-694. 137) Freedman J, Rubin B. Molteno implants as a treatment <strong>for</strong> refractory <strong>glaucoma</strong> in black patients. Arch Ophthalmol 1991;109:1417-1420. 138) Price FW Jr, Wellemeyer M. Long-term results of Molteno implants. Ophthalmic Sur 1995;26:130-135. 139) Perkins TW, Gangnon R, Ladd W, Kaufman PL, Libby CM. Molteno implant with mitomycin C: Intermediate-term results. JGlaucoma 1998;7:86-92. 140) Fellenbaum PS, Almeida AR, Minckler DS, Sidoti PA, Baerveldt G, Hever DK. Krupin disc implants <strong>for</strong> complicated <strong>glaucoma</strong>s. Ophthalmology 1994;101:1178-1182. 141) Britt MT, LaBree LD, Lloyd MA, Minckler DS, Heuer DK, Baerveldt G, Varma R. R<strong>and</strong>omized clinical trial of the 350-mm2 versus the 500-mm2 Baerveldt implant: longer term results: is bigger better Ophthalmology 1999;106(12):212-218. 142) Krishna R, Godfrey DG, Budenz DL, et al. Intermediate-term outcomes of 350 mm2 Baerveldt Glaucoma Implants. Ophthalmology 2001;108:621-626. 143) Siegner SW, Netl<strong>and</strong> PA, Urban RC Jr, et al. Clinical experience with the Baerveldt <strong>glaucoma</strong> drainage implant. Ophthalmology 1995;102:1298-1307. 144) Roy S, Ravinet E, Mermoud A. Baerveldt implant in refractory <strong>glaucoma</strong>: long-term results <strong>and</strong> factors influencing outcome. Int Ophthalmol 2001;24:93-100. 145) Coleman AL, Hill R, Wilson MR et al. Initial clinical experience with the Ahmed <strong>glaucoma</strong> valve implant. Am. J. Ophthalmol 1995;120:23-31. 146) Huang MC, Netl<strong>and</strong> PA, Coleman AL, et al. Intermediate-term clinical experience with the Ahmed <strong>glaucoma</strong> Valve implant. Am J Ophthalmol 1999;127:27-33. 147) Topouzis F, Coleman AL, Choplin N, et al. Follow-up of the original cohort with the Ahmed <strong>glaucoma</strong> valve implant. Am J Ophthalmol 1999;128:198-204. 148) Wilson MR, Mendis U, Smith SD, Paliwal A. Ahmed <strong>glaucoma</strong> valve implant vs trabeculectomy in the surgical treatment of <strong>glaucoma</strong>: a r<strong>and</strong>omized clinical trial. Am J Ophthalmol 2000;130:267-273. 149) Omi CA, De Almeida GV, Cohen R, et al. Modified Schocket implant <strong>for</strong> refractory <strong>glaucoma</strong>. Experience of 55 cases. Ophthalmology 1991;98:211-214. 150) Kwon YH, Taylor JM, Hong S, Honkanen RA, et al. Long-term results of eyes with penetrating keratoplasty <strong>and</strong> <strong>glaucoma</strong> drainage tube implant. Ophthalmology 2001;108:272-278. 151) G<strong>and</strong>olfi S, Traverso CE, Bron A, Sellem E, Kaplan-Messas A, Belkin M. Short-term results of a miniature draining implant <strong>for</strong> <strong>glaucoma</strong> in combined surgery with phacoemulsification. Acta Ophthalmol Sc<strong>and</strong> Suppl 2002; 236:66. 152) Spiegel D, Kobvch K. Trabecular Meshwork bypass tube shunt: initial case series Br J Ophthalmol 2002; 86:1228-1231. 153) Weinreb RN. Adjusting the dose of 5-fluorouracil after filtration surgery to minimize side effects. Ophthalmology 1987;94:564-570. 154) Feldman RM, Dietze PJ, Gross RL, Osman O. Intraoperative 5-Fluorouracil administration in trabeculec- Ch. 3 - 44 EGS
tomy. J. Glaucoma l994;3:302-307. 155) Hurvitz LM. 5FU supplemented phacoemulsification, posterior chamber lens implantation <strong>and</strong> trabeculectomy. Ophthalmic Surg 1993;24:674-680. 156) Kitazawa Y, Kawase K, Matsushita H, Minobe M. Trabeculectomy with mitomycin. A comparative study with fluorouracil. Arch Ophthalmol 1991;109:1693-1698. 157) Heuer DK, Parrish RK 2d, Gressel MG, Hodapp E, Palmberg PF, Anderson DR. 5-fluorouracil <strong>and</strong> <strong>glaucoma</strong> filtering surgery. II. A pilot study. Ophthalmology 1984;91:384-394. 158) Shin DH, Kim YY, Sheth N, Ren J, Shah M, Kim C, Yang KJ. The role of adjunctive mitomicin C in secondary <strong>glaucoma</strong> triple procedure as compared to primary <strong>glaucoma</strong> triple procedure. Ophthalmology 1998;105:740-745. 159) Wells A, Cordeiro M, Bunce CV, <strong>and</strong> Khaw PT. Cystic bleb related complications in limbus versus <strong>for</strong>nix based flaps in paediatric <strong>and</strong> young adult trabeculectomy with high dose mitomycin C. Invest Ophthalmol Vis Sci 2001;42(4):S544 160) Khaw PT, Wilkins M. Antifibrotic agents in <strong>glaucoma</strong> surgery. In: Yanof M, Dueker JS (eds.). Ophthalmology. London, Mosby 1998;12:31.1-31.8. 161) Khaw PT, Wells AP, Lim KS. Surgery <strong>for</strong> <strong>glaucoma</strong> in the 21st century. Br J Ophthalmol 2002;86(7):710-711. 162) Iester M, Ravinet E, Mermoud A. Postoperative subcongiuntival Mitomycin-C injection after non-penetrating <strong>glaucoma</strong> surgery. J Ocular Pharmacol Ther 2002;18:307-312. 163) Mietz A, Jacobi PC, Krieglstein GK. Postoperative application of mitomycin <strong>for</strong> trabeculectomies. Arch Ophthalmol 2000;18:1341-1348. 164) Cordeiro MF. Beyond Mitomicin: TGF β <strong>and</strong> wound healing - progress in retina <strong>and</strong> eye research 2002;21:75-89. Ch. 3 - 45 EGS
- Page 2 and 3:
ISBN: 88-87434-13-1 Editrice DOGMA
- Page 4 and 5:
ACKNOWLEDGEMENT This work was made
- Page 6 and 7:
2.2.5 - Primary Open-Angle Glaucoma
- Page 8 and 9:
Foreword These Definitions and Guid
- Page 10 and 11:
INTRODUCTION The aim of the book is
- Page 12 and 13:
Since resources are limited worldwi
- Page 14 and 15:
II - RANDOMIZED CONTROLLED TRIALS F
- Page 16 and 17:
II.3 - COLLABORATIVE NORMAL TENSION
- Page 18 and 19:
No stratification for stage of dise
- Page 20 and 21:
II. 6. 3 - from CNTG 1. Therapy tha
- Page 22 and 23:
References 1) The Ocular Hypertensi
- Page 24 and 25:
I - QUESTIONS TO ASK TO YOUR GLAUCO
- Page 26 and 27:
III - ABNORMAL THRESHOLD VISUAL FIE
- Page 28 and 29:
V - GONIOSCOPIC OPEN ANGLES SOME DI
- Page 30 and 31:
VII - TREATMENT STEPLADDER JUVENILE
- Page 32 and 33:
IX - MONOTHERAPY (in alphabetic ord
- Page 34 and 35:
XI - MANAGEMENT ACUTE ANGLE CLOSURE
- Page 36 and 37:
XIII - ANTIMETABOLITES FOR WOUND MO
- Page 38 and 39:
CHAPTER 1 PATIENT EXAMINATION
- Page 40 and 41:
Other methods 22-25 : Air-puff tono
- Page 42 and 43:
References 1) Martin XD. Normal int
- Page 44 and 45:
1.2 - GONIOSCOPY Gonioscopy is a fu
- Page 46 and 47:
1 2 3 4 Fig. 1 Dynamic indentation
- Page 48 and 49:
The Spaeth classification Insertion
- Page 50 and 51:
References 1) Palmberg P. Gonioscop
- Page 52 and 53:
small - size mid - size large - siz
- Page 54 and 55:
Fig. 5 A) Cirumlinear vessel, B) Ba
- Page 56 and 57:
1.3.4.3 - OCT The Optical Coherence
- Page 58 and 59:
31) Carpineto P, Ciancaglini M, Zup
- Page 60 and 61:
central 24 or 30 central degrees re
- Page 62 and 63:
A retinal sensitivity value worse t
- Page 64 and 65:
HODAPP CLASSIFICATION 31 EARLY GLAU
- Page 66 and 67:
References 1) Bengtsson B, Heijl A,
- Page 68 and 69:
1.5 - BLOOD FLOW 1.5.1 - VASCULAR F
- Page 70 and 71:
28) Flammer J, Orgul S, Costa VP, O
- Page 72 and 73:
All forms of glaucoma should be cla
- Page 74 and 75:
2.2 - PRIMARY OPEN-ANGLE GLAUCOMAS
- Page 76 and 77:
2.2.4 - PRIMARY OPEN-ANGLE GLAUCOMA
- Page 78 and 79:
2.3 - SECONDARY OPEN-ANGLE GLAUCOMA
- Page 80 and 81:
2.3.1.6 - Glaucoma due to intraocul
- Page 82 and 83: 2.4 - PRIMARY ANGLE-CLOSURE Primary
- Page 84 and 85: Systemic Risk factors for primary a
- Page 86 and 87: OCCLUDABLE ANGLE: “Occludable”
- Page 88 and 89: 2.5.3 - SECONDARY ANGLE-CLOSURE GLA
- Page 90 and 91: CHAPTER 3 TREATMENT PRINCIPLES and
- Page 92 and 93: Furthermore, blindness may occur de
- Page 94 and 95: T A R G E T I O P Target IOP range
- Page 96 and 97: Practical points for topical medica
- Page 98 and 99: 3.3.1.1 - Category: ADRENERGIC AGON
- Page 100 and 101: 3.3.1.2 - Category: ADRENERGIC ANTA
- Page 102 and 103: 3.3.1.3 - Category: CARBONIC ANHYDR
- Page 104 and 105: 3.3.1.4 - Category: PARASYMPATHOMIM
- Page 106 and 107: 3.3.1.5 - Category: PROSTAGLANDIN D
- Page 108 and 109: Drug interactions Precipitation occ
- Page 110 and 111: COMBINATION THERAPY Starting* Addit
- Page 112 and 113: 3.3.2.2 - Category: ADRENERGIC ANTA
- Page 114 and 115: Pregnancy and nursing mothers Only
- Page 116 and 117: 3.5 - LASER SURGERY 3.5.1 - LASER I
- Page 118 and 119: 3.5.2 - LASER TRABECULOPLASTY 77-89
- Page 120 and 121: 3.5.4 - CYCLOPHOTOCOAGULATION Indic
- Page 122 and 123: Although medical therapy is still t
- Page 124 and 125: 3.6.4 - COMPLEX CASES Complicated g
- Page 126 and 127: Post-operative use Concentration: 0
- Page 128 and 129: 25) Janz NK, Wren PA, Lichter PR, M
- Page 130 and 131: (Rescula TM ) in patients with glau
- Page 134 and 135: CHAPTER 4 TREATMENT GUIDELINES
- Page 136 and 137: 4.2 - PRIMARY OPEN-ANGLE GLAUCOMAS
- Page 138 and 139: 4.2.7 - OCULAR HYPERTENSION (OH) Al
- Page 140 and 141: 4.3.1.7 - Glaucoma associated with
- Page 142 and 143: • Withdrawal of aqueous from vitr
- Page 144 and 145: 4.5 - SECONDARY ANGLE-CLOSURE GLAUC
- Page 146 and 147: 4.5.3 - SECONDARY ANGLE-CLOSURE GLA
- Page 148 and 149: NOTES
- Page 150 and 151: NOTES
- Page 152: NOTES